Clinical Trials Browser

Phase 1/2 × INDUSTRY × AZD4547 × Clear all

NCT05086666 2021-10-21

A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547

Phase 1/2 Unknown

Carcinoma, Transitional Cell

NCT01202591 2016-02-11

GLOW

Phase 1/2 Completed

127 enrolled 8 charts

Breast Neoplasms